| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.04 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.04 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.04 |